U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
[_] Check box if no longer subject of Section 16. Form 4 or Form 5 obligations
may continue. See Instruction 1(b).
________________________________________________________________________________
1. Name and Address of Reporting Person*
Wicker Damion E.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
Chase Capital Partners
1221 Sixth Avenue-40th Floor
--------------------------------------------------------------------------------
(Street)
New York New York 10020
--------------------------------------------------------------------------------
(City) (State) (Zip)
Praecis Pharmaceuticals Incorporated ("PRCS")
________________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol
________________________________________________________________________________
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)
May 2000
_______________________________________________________________________________
4. Statement for Month/Year
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Year)
================================================================================
6. Relationship of Reporting Person to Issuer
(Check all applicable)
[X] Director [_] 10% Owner
[_] Officer (give title below) [_] Other (specify below)
________________________________________________________________________________
7. Individual or Joint/Group Filing (Check applicable line)
[X] Form filed by one Reporting Person
[_] Form filed by more than one Reporting Person
________________________________________________________________________________
================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
6.
4. 5. Owner-
Securities Acquired (A) or Amount of ship
3. Disposed of (D) Securities Form: 7.
Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of
2. Code ------------------------------- Owned at End (D) or Indirect
1. Transaction (Instr. 8) (A) of Month Indirect Beneficial
Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (mm/dd/yy) Code V (D) and 4) (Instr.4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Common Stock 5/2/00 C 7,339,004 A N/A 7,339,004 I (FN 1)
-----------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
* If the Form is filed by more than one Reporting Person, see Instruction
4(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
(Print or Type Responses)
(Over)
(Form 4-07/99)
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
10.
9. Owner-
Number ship
of Form
2. Deriv- of
Conver- 5. 7. ative Deriv- 11.
sion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
Exer- 4. Securities Date Securities Price Bene- ity: In-
cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene-
1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial
Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner-
Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship
Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
Series A, C,
and E Con-
vertible Pre- 7.47-7.51 Immed Common
ferred Stock for 1 5/2/00 C 978,708 (FN 2) N/A Stock 7,339,004 N/A 0 I (FN 1)
------------------------------------------------------------------------------------------------------------------------------------
Options $7.00 per Common
Share N/A N/A N/A N/A (FN 3) 11/0/09 Stock 30,000 N/A 30,000 D
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Explanation of Responses:
(1) The amounts shown represent the beneficial ownership of the Issuer's
equity securities by Chase Venture Capital Associates, LLC ("CVCA, LLC"), a
portion of which may be deemed attributable to the reporting person because
the reporting person is a general partner of Chase Capital Partners, which
is (i) the sole shareholder of the managing member of CVCA, LLC and (ii) the
the manager, by delegation, of CVCA, LLC. The actual pro rata portion of
such beneficial ownership that may be deemed attributable to the reporting
person is not readily determinable because it is subject to several
variables including CVCA, LLC'c internal rate of return and vesting.
(2) Upon the close of the initial public offering of the Issuer, all outstanding
shares of Convertible Preferred Stock were automatically converted into
Common Stock.
(3) The term of the option is for ten years from the date of the grant. These
options vest and become exercisable in equal monthly installments over a
three year period so long as Dr. Wicker continues to be a member of the
Board of Directors of the Issuer. As of May 31, 2000, options with respect
to 4,999 shares were vested and exercisable. Dr. Wicker is contractually
obligated to exercise the options at the request of, and to transfer any
shares issued under the stock options to CVCA, LLC.
/s/ Damion E. Wicker 6/7/00
--------------------------------------------- -----------------------
Damion E. Wicker Date
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
